ELCOM BIO TECHNOLOGY CO LTD has a total of 14 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Republic of Korea, Australia and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are KOTOSUGI INC, INDEPENDENT PHARMACEUTICA AB and DEZIMA PHARMA B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | Australia | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Foods | |
#5 | Unspecified technologies | |
#6 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Kim Young-Joong | 7 |
#2 | Kim So-Ra | 7 |
#3 | Sung Sang-Hyun | 7 |
#4 | Kim Yeong Jung | 5 |
#5 | Kim So Ra | 4 |
#6 | Sung Sang Hyeon | 4 |
#7 | Gu Gyeong-A | 4 |
#8 | Jeong Won-Ju | 4 |
#9 | Lee Mi-Gyeong | 4 |
#10 | Sang-Hyun Sung | 1 |
Publication | Filing date | Title |
---|---|---|
EP1326623A1 | Saururus chinensis extract for prevention and treatment of neurodegenerative disease | |
KR20020046356A | Use of dibenzylbutyrolactone lignan derivatives for treatment of neurodegenerative disease and pharmaceutical preparations containing them | |
KR20020044507A | Use of coumarin derivatives as anti-alzheimer's disease drugs and pharmaceutical preparations containing them as active ingredients | |
KR20020030649A | Pharmaceutical preparations containing an aristolactam alkaloid derivative for prevention and treatment of neurodegenerative disease | |
KR20020030648A | Saururus chinensis extract for prevention and treatment of neurodegenerative disease and pharmaceutical preparations containing the same | |
KR20020030642A | Pharmaceutical prepareations containing a dibenzocyclooctane lignan derivative for prevention and treatment of ischemic stroke by blocking neuronal cell death |